Therapeutic Plasmapheresis: A Revision of Literature

Background: Therapeutic plasmapheresis (TP) is an extracorporeal therapy that allows the removal of pathogens from plasma. The role of TP in immuno-mediated diseases and toxic conditions has been of interest for decades. Summary: We reviewed the recent literature on the application and the optimal choice of TP technique ranging from plasma exchange, double filtration plasmapheresis, rheopheresis, immunoadsorptions, plasma adsorption perfusion and lipidoapheresis. In addition, we report our experience in the application of TP for various diseases ranging in different medical specialties, following the American Society for Apheresis (ASFA) recommendations. Key Messages: Overall patients receiving TP showed an improvement in clinical and laboratory parameters. Our review and single-center experience suggest a benefit of the application of TP in multiple clinical disciplines.

• Publication year

  2022

• Venue

  Kidney & Blood Pressure Research

• Publication date

  2022-12-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000528556PMID 36481657PMCID 9932846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The scientific basis and future of lipoprotein apheresis

  2021cited by this paper
• Hydroxytyrosol Selectively Affects Non-Enzymatic Glycation in Human Insulin and Protects by AGEs Cytotoxicity

  2021cited by this paper
• Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications

  2021cited by this paper
• Therapeutic plasma exchange in pregnancy: A literature review.

  2021cited by this paper
• Double filtration plasmapheresis: Review of current clinical applications

  2020cited by this paper
• Membrane-Based Therapeutic Plasma Exchange in Intensive Care

  2020cited by this paper
• Physiological role of plasma and its components and the clinical implications of different methods of apheresis: A narrative review

  2020cited by this paper
• Relapsing and Progressive Complications of Severe Hypertriglyceridemia: Effective Long-Term Treatment with Double Filtration Plasmapheresis

  2020cited by this paper
• Effects of therapeutic plasma exchange on anticoagulants in patients receiving therapeutic anticoagulation: a systematic review

  2019influential reference
• Therapeutic plasma exchange - A brief review of indications, urgency, schedule, and technical aspects.

  2019cited by this paper
• Current Role of Lipoprotein Apheresis

  2019cited by this paper
• Role of Lipoprotein Apheresis in Cardiovascular Disease Risk Reduction

  2019cited by this paper
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

  2019cited by this paper
• Immunadsorption in der Dermatologie

  2018cited by this paper
• An update on LDL apheresis for nephrotic syndrome

  2018cited by this paper
• Vascular access for therapeutic plasma exchange

  2018cited by this paper
• Double filtration plasmapheresis: Determination of the optimal albumin concentration in the supplementation fluid.

  2017cited by this paper
• Immunoadsorption using Immusorba TR and PH.

  2017cited by this paper
• Immunoadsorption for collagen and rheumatic diseases.

  2017cited by this paper
• [Apheresis Techniques].

  2017cited by this paper
• Immunoadsorption in neurological disorders.

  2017cited by this paper
• Lipoprotein apheresis in patients with peripheral artery disease and lipoprotein(a)-hyperlipoproteinemia: 2-year follow-up of a prospective single center study.

  2017cited by this paper
• Adverse events in apheresis: An update of the WAA registry data.

  2016influential reference
• Lipoprotein Apheresis.

  2016cited by this paper
• Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidates

  2016cited by this paper
• Double Filtration Plasma Apheresis Shortens Hospital Admission Duration of Patients With Severe Hypertriglyceridemia-Associated Acute Pancreatitis

  2016cited by this paper
• [DFPP in myasthenia gravis: case report].

  2015cited by this paper
• Treatment of minor severe acquired haemophilia. Is there a rationale for immunoadsorption?

  2015cited by this paper
• The mechanisms of action of plasma exchange

  2014cited by this paper
• Current topics in therapeutic plasmapheresis

  2014cited by this paper
• Acute and chronic effects of therapeutic apheresis.

  2013cited by this paper
• [Plasmapheresis in intensive care].

  2012cited by this paper
• HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures

  2012cited by this paper
• A Critical Review on the Use of Lipid Apheresis and Rheopheresis for Treatment of Peripheral Arterial Disease and the Diabetic Foot Syndrome

  2012cited by this paper
• LDL-Apheresis: Technical and Clinical Aspects

  2012cited by this paper
• Immunoadsorption in dermatology

  2010cited by this paper
• Treatment with HELP‐apheresis in patients suffering from sudden sensorineural hearing loss: A prospective, randomized, controlled study

  2010cited by this paper
• [Rheopheresis for age-related macular degeneration].

  2009cited by this paper
• Heparin-induced Extracorporal LDL Precipitation (H.E.L.P) in Diabetic Foot Syndrome – Preventive and Regenerative Potential?

  2008cited by this paper
• Fibrinogen Apheresis in the Treatment of Peripheral Arterial Disease

  2007cited by this paper
• Clinical outcomes and mechanism of action for rheopheresis treatment of age‐related macular degeneration (AMD)

  2005cited by this paper
• The low-throughput protein A adsorber: an immune modulatory device. Hypothesis for the mechanism of action in the treatment of rheumatoid arthritis

  2005cited by this paper
• Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action.

  2005cited by this paper
• Acute Effect of Rheopheresis on Peripheral Endothelial Dysfunction in Patients Suffering From Sudden Hearing Loss

  2005cited by this paper
• Rheopheresis for sudden hearing loss (SHL).

  2004cited by this paper
• Bilirubin-Adsorption in 23 Critically Ill Patients with Liver Failure

  2004cited by this paper
• Immusorba TR and PH

  2003cited by this paper
• Approach to evidence based therapeutic apheresis.

  2003cited by this paper
• LDL apheresis.

  2003cited by this paper
• A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children.

  2003cited by this paper
• An approach to evidence‐based therapeutic apheresis

  2002cited by this paper
• [LDL apheresis].

  2001cited by this paper
• Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.

  2001cited by this paper
• A Practical Guide to Therapeutic Plasma Exchange

  1999influential reference
• Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.

  1999cited by this paper
• Ig-Therasorb immunoadsorption for selective removal of human immunoglobulins in diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins.

  1998cited by this paper
• LDL-Therasorb immunoadsorption for the treatment of severe hypercholesterolemia refractory to conventional therapy.

  1998cited by this paper
• Bilirubin adsorbent column for plasma perfusion.

  1998cited by this paper
• Efficacy and Safety of Immunoglobulin Apheresis

  1997cited by this paper
• Vascular access for therapeutic plasma exchange.

  1994influential reference
• Anaphylactoid reactions and bradykinin generation in patients treated with LDL-apheresis and an ACE inhibitor.

  1993cited by this paper
• Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.

  1993cited by this paper
• Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitors.

  1992cited by this paper
• Effect of low fibrinogen concentrations on the rheology of human blood in vitro.

  1979cited by this paper
• A study of methods for the prediction of plasma volume.

  1955influential reference

• Mechanisms of immune modulation by therapeutic plasma exchange.

  2026cites this paper
• Plasma-based strategies for systemic rejuvenation: critical perspectives on clinical translation.

  2026cites this paper
• A Perplexing Plexopathy After Pembrolizumab Therapy in Early-Stage Triple-Negative Breast Cancer.

  2026cites this paper
• Recent Progress in Double Filtration Plasmapheresis

  2025cites this paper
• Evaluation of clinical response according to category and level of evidence for therapeutic plasma exchange indications: A Single-Center Experience

  2025cites this paper
• Potential of Therapeutic Apheresis for Prolongation of Pregnancy in Early-Onset Preeclampsia

  2025cites this paper
• Therapeutic Plasma Exchange in Intensive Care Units—A 5-Year Multicenter Retrospective Study

  2025influential citation
• Pacientes de alto riesgo inmunológico: la carrera en la desensibilización

  2025cites this paper
• Therapeutic potential of plasmapheresis in lupus erythematosus: Biomarkers and follow-up control

  2025cites this paper
• Therapeutic Plasma Exchange: Analysis of Practices and Compliance With International Guidelines

  2025cites this paper
• Therapeutic plasma exchange via membrane filtration: A single-center experience

  2025cites this paper
• Therapeutic Plasma Exchange Experience in Internal Medicine Clinics: a Retrospective Review of 1,048 Procedures

  2025cites this paper
• Spectral Analysis of AVF Signals for Early Dysfunction Detection: Towards AI-Based Home Monitoring

  2025cites this paper
• Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial

  2025cites this paper
• Plasmapheresis for lowering the risks of placenta-associated complications in antiphospholipid syndrome

  2025cites this paper
• Safety profile of therapeutic plasma exchange in neurological diseases: Insights from a Polish intensive care unit.

  2025cites this paper
• Ornidazole-Induced Liver Injury: The Clinical Characterization of a Rare Adverse Reaction and Its Implications from a Multicenter Study

  2025cites this paper
• Pediatric stiff-person syndrome and related disorders: A systematic review

  2025cites this paper
• Recombinant ADAMT S-13 as a new alternative for the patients with congenital thrombocytopenic purpura

  2024cites this paper
• Nonspecific Orbital Inflammation (NSOI): Unraveling the Molecular Pathogenesis, Diagnostic Modalities, and Therapeutic Interventions

  2024cites this paper
• Therapeutic plasma exchange in critically ill children: 18-year experience of a tertiary care paediatric intensive care unit.

  2024cites this paper
• Healthy blood, healthy brain: a window into understanding and treating neurodegenerative diseases

  2024cites this paper
• Oral management for a patient with trismus accompanied by Isaacs’ syndrome: a case report

  2024influential citation
• Undercover lung damage in pediatrics - a hot spot in morbidity caused by collagenoses

  2024cites this paper
• A diagnostic challenge – autoimmune encephalitis as paraneoplastic syndrome of ovarian teratoma. Current state of knowledge

  2024cites this paper
• Effects of Rheopheresis in dialysis patients with peripheral artery disease and diabetic foot ulcers: A multicentric Italian study

  2024cites this paper
• Effect of Follicular T Helper and T Helper 17 Cells-Related Molecules on Disease Severity in Patients with Myasthenia Gravis

  2024cites this paper
• Effectiveness of double-filtration plasmapheresis in reducing immunoglobulin and culprit antibody levels in neuroimmune disorders: A single-center retrospective analysis from China.

  2024cites this paper
• Therapeutic plasma exchange without anticoagulation: Single-center experience.

  2024cites this paper
• Pancreatitis Secondary to Dyslipidemia: An Understudied Condition

  2024cites this paper
• Advances in Diagnosis and Management of Atypical Demyelinating Diseases.

  2024cites this paper
• Reperfusion injury or cytokine storm? Utilizing plasmapheresis in severe trauma-induced multiorgan failure: a case report

  2024cites this paper
• Increasing incidence of mycotoxicosis in South-Eastern Germany: a comprehensive analysis of mushroom poisonings at a University Medical Center

  2024cites this paper
• Therapeutic plasma exchange in critical illness

  2023cites this paper